By the end of this topic, the student should be able to:
Figure 1. The Socio-ecological Framework (Jalali et al., 2020)
Jalali et al. (2020) Propose a Socio-ecological Framework that includes Individual, Interpersonal Community and Society to explain and illustrate the interconnection of risk factors for opioid misuse.
Trauma has been described as resulting from three ‘E’s (SAMSHA, 2014):
Experience with one or more traumatic events can alter an individual’s capacity to cope. Trauma can include, but is not limited to, traumatic early life experiences, child abuse, neglect, witnessing or experiencing violence, sexual abuse, war, natural disaster, sudden unexpected loss, feeling life is out of one’s control, poverty, having a life-threatening illness, and intergenerational events.
Adopting a Trauma-informed approach to care is essential to care – particularly in the context of opioid use and opioid use disorders. A trauma-informed approach Realizes the impact of trauma, Recognizes the signs and symptoms of trauma, Responds on a multi-system level and Resists re-traumatization (SAMSHA, 2014).
Figure 3:
Source: U.S. Center for Preparedness and Response, 2020
Purkey, Patel and Phillips (2018) Contextualize the principles of Trauma Informed Care presented in Figure 3 to primary care practice in a 5 step process:
Step 1: Bear witness to the persons experience of trauma
Step 2: Help persons feel they are in a safe space and recognize their need for physical and emotional safety
Step 3: Include persons in the healing process
Step 4: Believe in the person’s strength and resilience
Step 5: Incorporate processes that are sensitive to a person’s culture, ethnicity, and personal and social identity.
To read more about this contextualization, consider retrieving the article.
Further reading: Nathoo, T., Poole, N. and Schmidt, R. (2018). Trauma-Informed Practice and the Opioid Crisis: A Discussion Guide for Health Care and Social Service Providers. Vancouver, BC: Centre of Excellence for Women’s Health.
Figure 4. Continuum of care
Conducting an assessment for individuals from different backgrounds
Opioid use and opioid-related harms can affect different communities and demographics in different ways. For example:
The examples above can reinforce attitudes and beliefs about opioid use for clients who can identify with one or more of them.
If you were to encounter an individual who was affected by the opioid crisis, reflect on how your knowledge about opioid use could positively inform your interaction and reflect on how your biases might negatively impact your interaction with that individual.
Belzak, L., & Halverson, J. (2018). Evidence synthesis—The opioid crisis in Canada: A national perspective. Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice, 38(6), 224.
British Columbia Coroners Service. (2019). Fentanyl-detected suspected illicit drug toxicity deaths, 2012–2019. https://www2.gov.bc.ca/assets/gov/birth-adoption-death-marriage-and-divorce/deaths/coroners-service/statistical/fentanyl-detected-overdose.pdf
Braveman, P., & Gottlieb, L. (2014). The social determinants of health: It's time to consider the causes of the causes. Public Health Reports, 129(Suppl. 2), 19–31.
Canadian Centre on Substance Use and Addiction. (2018). Canadian substance use costs and harms 2007–2014. https://www.ccsa.ca/sites/default/files/2019-04/CSUCH-Canadian-Substance-Use-Costs-Harms-Report-2018-en.pdf
Canadian Institute for Health Information. (2018). Opioid-related harms in Canada.
Canadian Mental Health Association. (2018). Care not corrections: Relieving the opioid crisis in Canada. https://cmha.ca/wp-content/uploads/2018/04/CMHA-Opioid-Policy-Full-Report_Final_EN.pdf
Canadian Psychological Association. (2019). Recommendations for addressing the opioid crisis in Canada. https://cpa.ca/docs/File/Task_Forces/OpioidTaskforceReport_June2019.pdf
Emerson, B., Haden, M., Kendall, P., Mathias, R., & Robert Parker, R. (2005). A public health approach to drug control in Canada. Health Officers Council of British Columbia.
Center for Preparedness and Response. (2020). 6 guiding principles to a trauma-informed approach. https://www.cdc.gov/cpr/infographics/00_docs/TRAINING_EMERGENCY_RESPONDERS_FINAL.pdf
Center for Substance Abuse Treatment. (2006). Addressing diverse populations in intensive outpatient treatment. In Substance abuse: Clinical issues in intensive outpatient treatment (Treatment Improvement Protocol Series, No. 47) (Chapter 10). U.S. Substance Abuse and Mental Health Services Administration. https://www.ncbi.nlm.nih.gov/books/NBK64093/
First Nations Health Authority. (2017). Overdose data and First Nations in BC: Preliminary findings. http://www.fnha.ca/newsContent/Documents/FNHA_OverdoseDataAndFirstNationsInBC_PreliminaryFindings_FinalWeb.pdf
Fischer, B., & Argento, E. (2012). Prescription opioid related misuse, harms, diversion and interventions in Canada: A review. Pain Physician, 15(3 Suppl.), ES191–E203.
Gomes, T., Greaves, S., Martins, D., Bandola, D., Tadrous, M., Singh, S., Juurlink, D., Mamdani, M., Paterson, P., Ebejer, T., May, D., & Quercia, J. (2017). Latest trends in opioid-related deaths in Ontario: 1991 to 2015. Ontario Drug Policy Research Network. https://odprn.ca/wp-content/uploads/2017/04/ODPRN-Report_Latest-trends-in-opioid-related-deaths.pdf
Hadland, S. E., Wharam, J. F., Schuster, M. A., Zhang, F., Samet, J. H., & Larochelle, M. R. (2017). Trends in receipt of buprenorphine and naltrexone for opioid use disorder among adolescents and young adults, 2001–2014. JAMA Pediatrics, 171(8), 747–755. https://doi.org/10.1001/jamapediatrics.2017.0745
Hall, W. J., Chapman, M. V., Lee, K. M., Merino, Y. M., Thomas, T. W., Payne, B. K., Eng, E., Day, S. H., & Coyne-Beasley, T. (2015). Implicit racial/ethnic bias among health care professionals and its influence on health care outcomes: a systematic review. American Journal of Public Health, 105(12), e60–e76.
Health Canada. (2017). Baseline survey on opioid awareness, knowledge and behaviors for public education research report (Unpublished report). Prepared by Earnscliffe Strategy Group for Health Canada.
Health Canada. (2018). Synthetic opioids/novel psychoactive substances: Impact on Canada’s opioid crisis. https://www.who.int/medicines/news/2018/10Canada.pdf
Hughes, C. E., and Stevens, A. (2010). What can we learn from the Portuguese decriminalization of illicit drugs? British Journal of Criminology.
Kerr, T., Mitra, S., Kennedy, M.C., Mcneil, R., 2017. Supervised injection facilities in Canada: past, present, and future. Harm Reduction Journal 14.
King, N. B., Fraser, V., Boikos, C., Richardson, R., & Harper, S. (2014). Determinants of increased opioid-related mortality in the United States and Canada, 1990–2013: A systematic review. American Journal of Public Health, 104(8), e32–e42.
Jalali, M.S., Botticelli, M., Hwang, R.C., Koh, H.K., Mchugh, R.K., 2020. The opioid crisis: a contextual, social-ecological framework. Health Research Policy and Systems 18.
Leshner, A., & Mancher, M. (Eds.). (2019). Barriers to broader use of medications to treat opioid use disorder. In Medications for opioid use disorders save lives (pp. 127–135). National Academies Press. https://www.ncbi.nlm.nih.gov/books/NBK538936/pdf/Bookshelf_NBK538936.pdf
Nathoo, T., Poole, N., & Schmidt, R. (2018). Trauma informed practice and the opioid crisis: A discussion guide for health care and social service providers. Centre of Excellence for Women’s Health.
MacKay, R., & Tiedemann, M. (2015). Bill C-70: An Act to amend the Controlled Drugs and Substances Act and to make related amendments to other Acts. Library of Parliament.
McMaster, G. (2019). Opioid crisis has cost Canada nearly $5 billion in lost productivity, U of A student finds. Folio. https://www.folio.ca/opioid-crisis-has-cost-canada-nearly-5-billion-in-lost-productivity-u-of-a-student-finds/
Oliver, J., Coggins, C., Compton, P., Hagan, S., Matteliano, D., Stanton, M., St Marie, B., Strobbe, S., Turner, H. N., & American Society for Pain Management Nursing. (2012). American Society for Pain Management nursing position statement: Pain management in patients with substance use disorders. Journal of Addictions Nursing, 23(3), 210–222. https://doi.org/10.1097/JAN.0b013e318271c123
Ontario Agency for Health Protection and Promotion (Public Health Ontario). (2017). Opioid-related morbidity and mortality in Ontario. Queen’s Printer for Ontario. http://www.publichealthontario.ca/en/dataandanaly4cs/pages/opioid.aspx
Pain & Policy Studies Group, University of Wisconsin. (n.d.). Canada: Opioid consumption in morphine equivalence (ME), mg per person. http://www.painpolicy.wisc.edu/country/profile/Canada
Public Health Agency of Canada. (2018). Chief Public Health Officer’s report on the state of public health in Canada, 2018: Preventing problematic substance use in youth. https://www.canada.ca/content/dam/phac-aspc/documents/corporate/publications/chief-public-health-officer-reports-state-public-health-canada/2018-preventing-problematic-substance-use-youth/2018-preventing-problematic-substance-use-youth.pdf
Public Health Agency of Canada. (2019). Government of Canada supports efforts to better understand how substance use affects Indigenous communities [News release]. https://www.canada.ca/en/public-health/news/2019/07/government-of-canada-supports-efforts-to-better-understand-how-substance-use-affects-indigenous-communities.html
Purkey,E., Patel, R., & Phillips, S. (2018). Trauma-informed care: Better care for everyone.
Canadian Family Physician, 64 (3) 170-172.
SAMSHA (2014). Concept of trauma and guidance for a trauma-informed approach. Retrieved from: https://store.samhsa.gov/product/SAMHSA-s-Concept-of-Trauma-and-Guidance-for-a-Trauma-Informed-Approach/SMA14-4884
Sherlock T. (2018). Could decriminalization be the answer to B.C.’s overdose crisis? National Observer. https://www.nationalobserver.com/2018/10/03/opinion/could-decriminalization-be-answer-bcs-overdose-crisis
Special Advisory Committee on the Epidemic of Opioid Overdoses. (2019). National report: Opioid-related harms in Canada. Public Health Agency of Canada. https://health-infobase.canada.ca/substance-related-harms/opioids
Stahler, G. J., & Mennis, J. (2018). Treatment outcome disparities for opioid users: Are there racial and ethnic differences in treatment completion across large US metropolitan areas? Drug and Alcohol Dependence, 190, 170–178. https://doi.org/10.1016/j.drugalcdep.2018.06.006
Taha, S. (2018). Best practices across the continuum of care for treatment of opioid use disorder. Canadian Centre on Substance Use and Addiction.
Taha, S., Maloney-Hall, B., & Buxton, J. (2019). Lessons learned from the opioid crisis across the pillars of the Canadian drugs and substances strategy. Substance Abuse Treatment, Prevention, and Policy, 14(1), 1–10.
Tu, H., & Cole, K. (2017). Respectful language and stigma regarding people who use substances. Provincial Health Services Authority, BC Centre for Disease Control, Toward the Heart. http://www.bccdc.ca/resource-gallery/Documents/respectful-language-and-stigma-final_244.pdf
U.S. Substance Abuse and Mental Health Services Administration, & Office of the U.S. Surgeon General. (2016). Health care systems and substance use disorders. In Facing addiction in America: The Surgeon General's report on alcohol, drugs, and health (pp. 244–314). U.S. Department of Health and Human Services.